Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488

Falling Comet

Download real time

6100.00 127.50 (2.13%)

289.2K

NSE+BSE Volume

NSE 20 Mar, 2026 3:31 PM (IST)

Patent Expiry

Divi's Labs soars on Friday as Novo Nordisk's patent for Semaglutide is set to expire on Saturday See details

Divi's Laboratories News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Divi's Laboratories from all sources in a single place.

Is Divi's Laboratories Ltd. worth buying?

756 Votes:

Buy 78.17%

Sell 14.95%

Hold 6.88%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Accumulate SEE REPORTS >